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Abstract 
Background 
Vascular elasticity is crucial for maintaining hemodynamics. Molecular mechanisms involved 
in human elastogenesis are incompletely understood. We describe a syndrome of lethal 
arteriopathy associated with a novel, identical mutation in the fibulin 4 gene (FBLN4) in a 
unique cohort of infants from South India. 
Methods 
Clinical characteristics, cardiovascular findings, outcomes and molecular genetics of twenty-
two infants from a distinct population subgroup, presenting with characteristic arterial 
dilatation and tortuosity during the period August 2004 to June 2011 were studied. 
Results 
Patients (11 males, 11 females) presented at median age of 1.5 months, belonging to 
unrelated families from identical ethno-geographical background; eight had a history of 
consanguinity. Cardiovascular features included aneurysmal dilatation, elongation, tortuosity 
and narrowing of the aorta, pulmonary artery and their branches. The phenotype included a 
variable combination of cutis laxa (52 %), long philtrum-thin vermillion (90 %), 
micrognathia (43 %), hypertelorism (57 %), prominent eyes (43 %), sagging cheeks (43 %), 
long slender digits (48 %), and visible arterial pulsations (38 %). Genetic studies revealed an 
identical c.608A > C (p. Asp203Ala) mutation in exon 7 of the FBLN4 gene in all 22 patients, 
homozygous in 21, and compound heterozygous in one patient with a p. Arg227Cys mutation 
in the same conserved cbEGF sequence. Homozygosity was lethal (17/21 died, median age 4 
months). Isthmic hypoplasia (n = 9) correlated with early death (≤4 months). 
Conclusions 
A lethal, genetic disorder characterized by severe deformation of elastic arteries, was linked 
to novel mutations in the FBLN4 gene. While describing a hitherto unreported syndrome in 
this population subgroup, this study emphasizes the critical role of fibulin-4 in human 
elastogenesis. 
Keywords 
Arterial tortuosity, fibulin-4 mutation, aortic aneurysm, vascular elasticity, genetic 
vasculopathy, Mappila muslims, founder effect, cardiovascular imaging, lethal mutation, 
connective tissue disorder, abnormal elastogenesis, Malabar. 
Background 
Vascular structure and integrity are determined by connective tissue elements, which include 
elastic fibers, collagen and several glycoproteins. Cardiovascular abnormalities resulting 
from inherited defects of many of these components are well known, e.g. Marfan syndrome 
(fibrillin-1) (MFS; MIM #154700), Williams-Beuren syndrome (elastin) (WBS; 
MIM#194050), vascular Ehlers-Danlos syndrome (type III collagen) (vEDS; MIM # 
130050), and hereditary cutis laxa syndromes (elastin and fibulin-4 and 5) (ADCL1 and 
ARCL1A; MIM #123700, 219100). However, some of the most dramatic vascular 
manifestations observed occur in a group of rare disorders which includes Arterial Tortuosity 
Syndrome (ATS; MIM #208050), Loeys-Dietz Syndrome (LDS; MIM #609192) and 
Autosomal Recessive Cutis Laxa (ARCL) type I. ATS is an autosomal recessive disorder 
attributed to mutations in the SLC2A10 gene (chromosome 20q13) [GenBank:AF321240.1] 
[1]; LDS is an autosomal dominant disorder associated with heterozygous mutations in genes 
encoding the transforming growth factor beta receptors (TGFBR) 1 and 2 
[GenBank:GU143401.1 and GU143402.1] [2]. It has been shown that perturbations in the 
TGF beta pathway contribute to the pathogenesis of some of the above-mentioned disorders. 
Despite the dramatic vascular phenotype and associated morbidities [3-6] ATS and LDS are 
reported to have a natural history permitting survival of several patients to adulthood [2,5-7]. 
ARCL Type I is characterized by cutis laxa, pulmonary emphysema, umbilical and inguinal 
hernias and gastrointestinal and vesico-urinary tract diverticuli, described in association with 
mutations of fibulin-5 [8] [GenBank:BC022280.1] and fibulin-4 [9] [GenBank:AF109121.1]. 
Though each of these disorders has characteristic phenotypic features [2,3,5,7-16], the 
dominating common features are dilatation, elongation and tortuosity of the large and 
medium sized arteries. 
The large arteries (aorta and its branches, pulmonary arteries) are distinguished by their 
elasticity, which allows them to expand and recoil with cardiac contraction and relaxation, 
maintaining blood pressure and hemodynamics. This property is largely attributable to elastic 
fibers [17,18] present as sheets (lamellae) in the tunica media as well as, in sparser quantities, 
in internal elastic lamina and along with collagen in the tunica adventitia. Loss of elasticity 
can result in deformation in response to the constant hemodynamic stresses. While elastic 
fibers constitute only 2-3 % of skin tissue, they contribute to nearly 50 % of dry weight of 
elastic arteries [19]. Mature elastic fibers are composed of central amorphous elastin (derived 
from its soluble precursor, tropoelastin), surrounded by a scaffold of microfibrils. 
Microfibrils contain numerous proteins such as microfibrillar-associated glycoprotein, 
fibrillin and fibulin [17,18]. Recent studies have shown direct structural and regulatory roles 
of fibulin-4 and −5 in elastogenesis [20,21]. In addition, it has been postulated that mutations 
in fibulin-4 and −5 may impair elastogenesis through modulation of the TGF β signaling 
pathways [22]. The steps in elastogenesis and role of different molecules in formation and 
stabilization of elastic fibers are complex and incompletely understood [17]. 
This study characterizes a cohort of twenty-two infants from an identical ethno-social 
background with a lethal syndromic vasculopathy associated with a novel mutation in 
FBLN4, confirming fibulin-4 as a critical determinant in human elastogenesis. 
Results 
Clinical evaluation 
Twenty-two patients (11 males, 11 females) were studied. All patients belonged to unrelated 
families from the same ethno-religious group (Muslim) hailing from the same geographical 
area, northern coastal (“Malabar”) belt of the southern Indian state of Kerala. Muslims of 
Malabar constitute a distinct community, commonly called “Mappilas”. 
Table 1 shows the clinical profiles, family history and phenotypic features (Figure 1A, 1B). 
All patients had normal birth weights (median 2.96 kg). Two infants presented initially with 
an incidentally detected murmur, all others presented with cardiorespiratory distress. Six 
patients presented in neonatal period, two of them with severe cardiorespiratory distress and 
refractory shock within hours of birth. Vasculopathy was diagnosed at a median age of 1.75 
months (1 day to 15.5 months). Antenatal history, routine fetal scans, and birth history were 
unremarkable in all except for one patient (proband 20) who was detected to have an 
excessively dilated aorta and pulmonary artery in third trimester fetal ultrasonogram. None of 
the other patients had undergone third-trimester fetal ultrasonography. 
Table 1 Clinical and Phenotypic features 
 CLINICAL PHENOTYPIC FEATURES 
S.No Sex Age At 
Diagnosis 
(Months) 
Birth 
order 
Consanguinity Family 
history 
Cutis 
laxa 
Hernia Prominent 
eyes 
Hypotonia Micrognathia Hypertelorism Long Philtrum, 
Thin Vermillion 
Joint 
laxity 
Abnormal 
ears 
Broad 
Forehead 
Thin, Long 
digits 
Sagging 
cheeks 
Hooded 
eyes 
High arched 
palate 
Seizures 
1 M 1.5 2 No Yes - - - + + - + - - - - - - + - 
2 M 2 4 Yes No - - - - - + + - - + - - - - - 
3 F 1.2 2 Yes No + - - + - + + - - - - - - - - 
4 M 4 2 Yes No + + - + + + + - - + - + + - - 
5 M 8 2 No No + + + + - + - - + - - + + + - 
6 F 9 1 No No + + + + - + + + - - - + + + - 
7 F 0.5 1 Yes No - - - - + - + - - - + - - - - 
8 F 9 2 No Yes - - - - - + - + - - - - + - - 
9 M 0.03 1 Yes No - - - - + - + - + - + - - - - 
10 F 1.5 1 No No + - + - + - + + + - + + + + - 
11 F 15 2 No No + - + - + - + - - + + + + - - 
12 M 1.2 1 No No + - + - + + + - - - + + - + + 
13 M 1 1 No No + - + - - - + - + - + - - - + 
14 M 0.5 4 No Yes - - - - - - + - - - - - - - - 
15 M 1.5 1 Yes No - - - - + - + - - - - - - - - 
16 F 0.03 1 Yes No NA NA NA NA NA NA NA NA NA NA NA NA NA NA - 
17 F 2 1 No No + - + - - + + - - + + - - + - 
18 F 6 2 No Yes - - - + - + + - - - + + - - - 
19 F 17 4 Yes Yes + + - + - + + + - - - - - - - 
20 F 12 1 No No - - - + - - + + - + - - - + - 
21 M 0.9 1 No No + - + + - + + - - + + + - + + 
22 M 0.5 1 No No - - + - + + + + - - + + - - + 
Figure 1 Clinical features and histopathology. 1A: Typical facial features – long philtrum 
thin upper lip, prominent eyes, broad forehead, sagging cheeks and lateral part of upper 
eyelids. 1B : Cutis laxa with redundant axillary skin folds (arrows). 1C : Chest 
roentgenogram (Antero-posterior view) – aortic enlargement evident as mediastinal 
widening. Dilated descending aortic shadow seen in right hemithorax just above the level of 
the diaphragm. 1D : Echocardiogram showing dilated descending thoracic aorta (AoDt) 
compressing upon the left heart structures (LA – left atrium, LV – left ventricle). [Figures 
1A-1D belong to Proband 5]. 1E and 1 F : Orcein-stained skin biopsies from an age-matched 
control and proband 10 respectively, showing the abundant, dark stained elastic fibers in the 
control and severely deficient and fragmented elastic fibers in patient 
Eight of the patients were born out of third degree consanguineous marriages (between first 
cousins). Four families (probands 1, 14, 18, 19) had a history of death of a previous infant 
(age at death 4, 11, 12 and 24 months, respectively), all of whom were noted to have 
respiratory distress in association with at least one of the following - dilated great arteries 
(n = 2), loose skin (n = 2), or inguinal/abdominal hernia (n = 2). The mother of proband 18 had 
history of third trimester fetal loss from unknown cause. 
The phenotype included variable combination of features, as listed in Table 1. The facial 
appearance was characteristic, with long philtrum and thin vermillion observed in 90 %; other 
features being hypertelorism (57 %), micrognathia (43 %), prominent eyes (43 %), sagging 
cheeks (43 %), high arched palate (38 %), hooded eyelids (29 %), broad forehead (29 %) and 
dysplastic/low set pinnae (19 %). Cutis laxa with redundant skin folds was seen in 52 %, 
most prominent in the axillary and anterior abdominal skin. Skin was hyperextensible in two 
patients. Thin long digits (48 %), generalized hypotonia (43 %), and herniae (19 %) were the 
other common physical features observed. 67 % (n = 14) of the patients had 5 or more of the 
listed features, 90.5 % (n = 19) had 3 or more, while only 9.5 % (n = 2) had less than 3. 
Pulsatile arterial vascular swellings (measuring 1.5 cm-3 cm) were a striking finding in 8 
patients, most prominently visible in the axilla, suprasternal, supraclavicular or 
submandibular locations (Additional file 1). No major skeletal abnormalities were noted in 
any patient. 
Delay in attainment of gross motor milestones was observed in all infants older than four 
months, mostly in association with generalized hypotonia and debility. 
Cardiovascular imaging 
The chest roentgenogram showed mediastinal widening with aortic dilatation (Figure 1C). 
Lung volumes were compromised by the enlarged great arteries within the thorax. The 
findings on cardiovascular imaging are summarized in Table 2 and shown in Figures 1D, 2A-
F, 3Ai, 3Aii and Additional file 2. Most striking in all patients were the impressive 
abnormalities of the aorta and pulmonary arteries, and their branches. While ascending and 
descending thoracic aorta, and the main pulmonary artery, were elongated and dilated in all, 
some sites like the aortic isthmus, the origins of the arch branches (branchiocephalic, carotid 
and subclavian arteries), abdominal aorta and its branches and the branch pulmonary arteries, 
were prone to stenosis. All patients who had peripheral pulmonary stenosis showed 
consequent right ventricular hypertension. 
Table 2 cardiovascular manifestations 
Alteration in Arterial dimensions Absolute dimension (Range in mm) Z Score (Range) Median Z Score 
Dilatation of aortic root 14 to 30.4 +3.6 to +8.1 +4.6 
Dilatation of ascending aorta 14 to 35.9 +4.6 to +12.1 +7.6 
Dilatation of proximal transverse arch 6.5 to 29.1 −2.7 to +6.9 +3.4 
Narrowing of isthmus, coarctation 1.8 to 7 −6.5 to −0.4 −2 
Dilatation of main pulmonary artery 9.1 to 23.6 +0.5 to +7 +4.1 
Other Major findings 
Aorta & branches 
Tortuosity and elongation of the arch branches – 22 
Origin stenosis of left subclavian artery – 5 
Origin stenosis/atresia of left common carotid artery – 4 
Origin stenosis of bilateral carotid arteries – 2 
Elongation and tortuous folding of thoracic aorta at diaphragm – 18 
Coeliac artery stenosis - 4 
Abdominal aortic dilatation – 6 
Abdominal aortic stenosis - 8 
Stenosis of superior mesenteric artery – 2 
Pulmonary arteries 
Right pulmonary artery stenosis – 8 
Left pulmonary artery stenosis – 2 
Early branching of the right pulmonary artery – 7 
Other findings 
Ventricular hypertrophy – 15 
Aortic regurgitation (mild) – 10 
Mitral regurgitation (mild) - 7 
Tracheal compression – 6 
Esophagial compression - 7 
Cerebral arterial elongation/tortuosity – 9 (of 11patients scanned for intracranial arteries) 
Cerebral infarctions - 3 
Table 2 summarizes the findings on cardiovascular imaging (echocardiography, 64-slice CT 
scan / MRI) 
Figure 2 Cardiovascular imaging. 2A-F : 64-slice cardiac CT images showing 
characteristic aneurysmal enlargement and tortuosity of aorta and arch branches. Note the 
narrow aortic isthmus (*) (2A,C,D,E), abdominal aortic stenosis (2D-F). AoAs – Ascending 
Aorta, AoDt- Descending Thoracic Aorta, AoAb – Abdominal Aorta 
Parental cardiovascular evaluation by echo or MRI was normal in all the nine cases studied. 
Cranial CT revealed elongation and tortuosity of cerebral arteries in nine patients, and signs 
of cerebral ischemia in three of these. The latter three had stenosis of the origin of common 
carotid arteries. Retinal vessels were found to be prominent but non-tortuous in both the 
patients subjected to retinal examination (probands 5 and 6). 
Progression of the vascular lesions was documented in CT scans repeated after 11 and 6 
months respectively for probands 4 and 5 as shown in Figures 3-Ai, Aii, Bi, Bii. Tracheal and 
esophageal compression observed on the CT correlated with their symptoms of positional 
(supine) dyspnea and dysphagia. 
Figure 3 Natural history and outcomes. 3Ai and 3Aii : Serial 64-slice CT scans done in 
Proband 4 after an interval of 11 months showing progressive enlargement and tortuosity of 
descending aorta. 3Bi and 3Bii : Graphs showing the increase in the absolute dimensions and 
the respective Z-scores, of Ascending Aorta, Aortic Root and Main Pulmonary Artery in 
serial 64-slice CT scans in Proband 4 (at interval of 11 months) and Proband 5 (at interval of 
6 months). 3C: Kaplan Meier Survival Graph for the homozygous mutant patients. 3D : 
Scatter diagram for the entire cohort, showing the ages at death. Currently surviving probands 
are encircled 
Histopathology 
Hematoxylin-eosin and Orcein staining of a skin biopsy of proband 10 showed deficient and 
fragmented elastic fibers in the subcutaneous layers, as compared to an age-matched control 
(Figure 1E,F). 
Molecular genetics 
In the absence of a precise molecular diagnosis in the initial period of the study, patients were 
assigned a provisional clinical diagnosis of Arterial Tortuosity Syndrome [23] on the basis of 
overlapping physical and vascular phenotype. Therefore, initially molecular analysis of the 
SLC2A10 gene was performed, but no disease-causing mutation was identified. Patients did 
not present with Loeys-Dietz syndrome strictly speaking, nevertheless mutations in the 
TGFBR1/2 genes were excluded by direct sequencing of both genes. Subsequently, direct 
sequencing of the FBLN4 gene revealed an identical homozygous c.608A > C (p. 
Asp203Ala) mutation in exon 7 in all patients except for the 8
th
 proband who showed 
compound heterozygosity for this mutation with a c.679C > T (p. Arg227Cys) mutation in the 
same calcium binding epidermal growth factor (cbEGF) domain. Parental DNA of 19 
probands were tested (both parents of 12 probands , and only maternal DNA of 7 probands). 
All parents tested were heterozygous for the same c.608A > C (p. Asp203Ala) mutation, 
except for the father of the compound heterozygote who did not bear any FBLN4 mutation, 
indicating that the p. Arg227Cys occurred de novo (with proven paternity). The presence of 
the mutations were excluded in 200 control alleles. In order to determine a common ancestry, 
we haplotyped several polymorphic markers surrounding the FBLN4 gene (D11S4205 – 0.2 
Mb – D11S1883 – 2 Mb – FBLN4 – 1.9 Mb – D11S1889 – 0.1 Mb – D11S4155 – 1.35 Mb – 
D11S4113 – 0.5 Mb – D11S4095). These analyses showed a shared haplotype for the 
following three markers: D11S1889, D11S4155, and D11S4113 in all probands. 
Outcome and natural history 
All patients were managed with symptomatic and supportive measures, using digoxin and 
diuretics where indicated, respiratory care, nutritional supplements and physiotherapy. Two 
patients (probands 1 and 2) received propranolol (2 mg/kg/day q 12 hours) and all the 
remaining homozygous mutant patients received losartan (0.5-1.5 mg/kg/day q 24 hours). 
Among the homozygous mutant patients (n = 21), 76.2 % (n = 17) died, median age of death 
being 4 months (36 hours-30 months, average 6.9 months) (Figure 3C-D), including 4 
neonatal deaths. Probands 9 and 16 had the shortest survival, dying at 36 hours and 48 hours 
of life respectively, following intractable cardiorespiratory failure and shock soon after birth. 
The other two neonatal deaths (probands 7 and 14) occurred at 15 days and 28 days, 
respectively, due to rapidly worsening cardiorespiratory failure. The remaining homozygous 
mutant patients also showed progressive worsening of symptoms; tachypnea and chest 
indrawing especially in the supine position, deterioration during respiratory infections, 
feeding difficulties, failure to thrive, increasing skin laxity (in patients who had cutis laxa 
initially), generalized hypotonia, and delayed motor development. Four patients (probands 
12, 13, 21, 22) developed generalized seizures on follow-up (in early infancy) and required 
anti-convulsants; all four had evidence of stenotic lesions in common carotid artery origins 
and/or in the smaller cerebral vessels (CT angiography). Only 6 of the 21 homozygous 
mutants survived beyond first year of life (probands 4,5,6,11,18,19), three of whom 
subsequently died between 14–17 months of age (probands 4,5,6). Proband 11 was the sole 
survivor beyond 2 years, dying eventually at 30 months. All patients who survived beyond 
first year of life showed preference for a lateral position while sleeping and leaning forward 
position while feeding, suggesting airway and esophageal compression (also demonstrated in 
CT/MRI). Arterial pulsations noted in axilla, neck and submandibular regions became more 
prominent on follow-up; newer pulsatile masses appeared in three patients on follow-up. The 
four surviving homozygous mutants, probands 18, 19, 21, 22 are currently aged 19, 22, 2 and 
2 months respectively. All four are receiving Losartan (1.5 mg/kg/day), digoxin and 
frusemide. Proband 21 developed hemopericardium and cardiac tamponade with intracranial 
bleed at 55 days of age requiring emergency pericardiocentesis and blood transfusion. CT 
Angiogram failed to reveal the site or cause of the pericardial and intra-cranial hemorrhage; 
coagulation parameters were normal. All the other three surviving patients have history of 
recurrent hospitalization for intermittent worsening of respiratory symptoms especially 
during respiratory infections, improving with medications. Proband 8, bearing the compound 
heterozygous mutations has remained asymptomatic and is currently 7 years old. 
Except for proband 17, none of the deaths occurred at our center; events surrounding death 
were noted by interviewing the care givers. Six deaths were precipitated by respiratory 
infections, and one was preceded by multiple generalized seizures. Terminal events in all 
were worsening cardiorespiratory symptoms and general debility. Vascular rupture as a 
terminal event could not be established in any of these patients, however the possibility 
cannot be excluded. None of the families consented for autopsy. 
Aortic isthmic hypoplasia (Z score ≤ −2, range −2.1 to −6.49, n = 9) correlated with early 
clinical presentation (≤ 2 months) and early death (≤ 4 months) (p value <0.0001). 
Antenatal counselling was offered to the mother of proband 1 during her subsequent 
pregnancy. Fetal echocardiogram and anomaly scans at 17 weeks of gestation were normal, 
but amniocentesis and mutation analysis revealed fetal homozygosity for the FBLN4 
mutation. The pregnancy was terminated at insistence of the family at 18 weeks. Autopsy and 
post-mortem aortogram did not reveal obvious arterial abnormalities. Fetal skin biopsy 
showed near-absence of elastic fibers. 
Discussion 
This study describes the spectrum of clinical features, natural history, and molecular genetics 
of a disorder resulting from a novel mutation in the gene encoding the fibulin-4 protein in a 
unique population subset. 
Fibulins constitute a recently recognized family of seven extracellular glycoproteins that 
interact with many extracellular matrix proteins including components of basement 
membranes and elastic fibers [24]. They are widely distributed throughout the body, 
especially in elastic-fiber rich tissues (aorta, lungs etc.). Fibulins contain contiguous calcium-
binding epidermal growth factor-like domains (cbEGF) and a characteristic C-terminal 
fibulin domain [25] (Figure 4B]. Fibulins-4 and −5 are implicated in elastogenesis [21,22,26]. 
Figure 4 Sequence alignment of fibulin-4 and location of mutations. 4A: Multiple 
sequence alignment of fibulin-4 protein sequence from (1) Homo sapiens, (2) Pan 
troglodytes*, (3) Canis lupus familiaris*, (4) Bos taurus, (5) Mus musculus, (6) Danio rerio ; 
sequences from species marked * were computationally predicted. cbEGF4 sequence is 
enclosed in the rectangular box. Substitutions within the domain are encircled. Arrow marks 
the position of aspartate 203 in human fibulin-4. Conservation of amino acid identity of this 
aspartate across species and its sequence position at start of the cbEGF4 domain, indicates its 
functional significance. All patients had identical missense mutation at this crucial position. 
4B : Schematic representation of domains, based on Swiss-Prot annotation [Swiss-
Prot:O95967]. The types of domain are listed on the left. Amino acid position in fibulin 4 
sequence is noted at start and end positions of the protein, the atypical cbEGF domain and the 
region containing 5 tandem cbEGF domains. Mutations listed on the right are found in human 
disease with the exception of I259V*. The D203A mutation (bold) is the one found in all 
patients in our cohort. Mutations shown in italics occurred in compound heterozygotes. 
References are shown in brackets 
Critical importance of fibulin-4 in elastogenesis has been shown in animal experimental 
models. Fibulin-4 knock-out mice showed severe vascular and lung defects and perinatal 
lethality due to abolition of elastogenesis [27]. Suppression of elastogenesis in fibulin-4 
knock-down mice also resulted in vascular tortuosity and aneurysms resembling human 
arterial tortuosity syndromes [22,28]. The role of fibulin-4 in human elastogenesis has been 
recently demonstrated experimentally in human foreskin fibroblast model [20]. However, 
reports of mutations in FBLN4 resulting in clinical disease in humans are rare. Hucthagowder 
et al. [9] identified a missense mutation (c.169 G > A; p.E57K) in FBLN4 in a child with 
multiple fractures, cutis laxa, vascular tortuosity and aneurysms, emphysema, inguinal and 
diaphragmatic hernia and joint laxity. Compound heterozygous mutations ((c.835C > T 
(p.R279C) / c.1070_1073dupCCGC) in FBLN4 causing a severe phenotype including cutis 
laxa and aortic aneurysm and tortuosity resulting in death at 27 days age was reported by 
Dasouki et al. [29]. Hoyer et al. reported a homozygous missense mutation (p. Cys267Tyr) in 
a female neonate with fetal overgrowth and oligohydramnios, arachnodactly, contractures, 
cutis laxa, microcephaly, spina bifida and extreme perinatal bradycardia leading to death 
[30]. This group of FBLN4 mutation-positive patients was doubled by the identification of 2 
homozygous (c.376 G > A; p. Glu126Lys, and c.1189 G > A; p. Ala397Thr) and 1 compound 
heterozygous mutations (c.377A > T: p. Glu126Val, and c.577delC; p. Gln193Ser fs X12) in 
three patients by Renard et al. [31]. These patients were clinically characterized by major 
cardiovascular defects (aortic aneurysms, arterial tortuosity, and stenosis) and a marked 
absence of severe skin involvement. All mutations in FBLN4 discussed here are depicted in 
Figure 4B. 
Mechanisms whereby fibulin-4 absence or deficiency results in aneurysm formation are not 
established. While Chen Q et al. [20] and Choudhary et al. [21] postulated direct structural 
role for fibulin-4 in elastic fiber assembly, Hanada et al. [22] postulated TGF beta 
upregulation as possible mechanism in the murine model. Renard et al. provided the first 
evidence of altered TGF beta signaling in humans with FBLN4 mutations [31]. Huang et al. 
observed that while Fbln4 null mice develop lethal aortic aneurysms, deficiency of other 
elastic elements like fibulin-5 and elastin were not associated with as severe aneurysm 
formation or lethality. They postulated a dual role for fibulin-4, in elastic fiber formation, as 
well as terminal differentiation and maturation of SMC (smooth muscle cells) in aortic wall 
[32]. 
We describe 22 new patients with an identical novel mutation in FBLN4, with severe vascular 
phenotype and lethal outcomes, providing the largest clinical evidence so far, for vital role of 
fibulin-4 in human elastogenesis. 
The first mutation identified was homozygous single base substitution (c.608A > C) in 21/22 
probands, resulting in p. Asp203Ala substitution which affects the highly conserved DVNE 
consensus sequence of the fourth cbEGF domain (Figure 4A). The consensus sequence is 
critical in binding calcium ions, which are essential for the structural and binding properties 
of the fibulin-4 protein. The second mutation, an argine 227 to cysteine substitution, of the 
compound heterozygote patient (proband 8) results in substitution of a positively charged 
arginine to a disulfide containing cysteine which may foster incorrect disulfide bond 
formation or interfere with other charge interactions important for protein structure stability, 
or functional interactions potentially leading to altered secretion into the extracellular matrix. 
The causal nature of the mutations is further supported by the following facts: (1) the 
mutations were not present in 200 control alleles, (2) they affected highly conserved amino 
acids and nucleotides (Figure 4A), (3) by its de novo occurrence (p. Arg227Cys), (4) the 
mutations are predicted to have a pathogenic effect based on in silico prediction software 
(SIFT: deleterious (score 0.00); Polyphen2: probably damaging (score 1.000); Align GVGD: 
class65 (GV 0.00 – GD 125.75)), and (5) the mutations lead to an amino acid change which 
results in a moderate (p. Asp203Ala, Grantham score 126, acidic to hydrophobic amino acid) 
to large (p. Arg227Cys, Grantham score 180, basic to hydrophobic amino acid) 
physicochemical difference. 
The unique social background of our patients is intriguing. The northern coast of Kerala 
(Malabar) has a population of about 17.5 million, and a large proportion of the Muslims in 
Kerala (about 24 %) [33] (Figure 5). The ports of Malabar were historically important as hubs 
of sea trade in ancient and medieval India. Mappilas of Malabar are historically regarded as 
the first Muslims in India, many of them originally descended from Arab settlers who 
brought the religion to this region as early as 7
th
 century AD [34]. Consanguineous marriages 
are common among this distinct sub-population. Most marriages are arranged within the 
Mappila community even in the current era. The presence of a shared haplotype including the 
FBLN4 gene among the families in our cohort strongly suggests a common ancestry for all 
probands. Limited size of the shared haplotype block (max 5.85 Mb), favors the existence of 
a relatively old founder. The significance of this unique historical/ethnic background needs 
further evaluation. No major studies exist on the genetic profile or diseases specific to this 
community. The finding that all parents tested (except father of proband 8) in this cohort 
were heterozygous for the same mutation, bearing normal phenotype, suggests that the 
mutation is not lethal in its heterozygous state and therefore allows transmission. 
Figure 5 Map of India. Political map of India showing the state of Kerala (panel inset) and 
the Malabar region (encircled). Source : Wikimedia 
All homozygous mutant patients showed early presentation and high lethality. Only 4/22 
homozygous mutants currently survive. Correlation of aortic isthmic hypoplasia with early 
clinical presentation and death implicates severity of coarctation as an important predictor of 
outcomes. Neonatal presentation and death in four, as well as the 3
rd
 trimester antenatal 
detection of vascular dilatation in one patient implies presence of advanced vascular lesions 
at birth in at least some of these patients. Although the terminal event in most appeared to be 
worsening cardiorespiratory failure, inability to subject these patients to autopsy limits our 
understanding. Notably, proband 8 bearing a compound heterozygous mutation is surviving 
with no major symptoms despite having vascular abnormalities similar to the homozygotes (Z 
scores: aortic root, +8.14; ascending aorta, +12.14; isthmus, -1.55; MPA, +3.41). Even 
though survival may be linked to absence of severe coarctation, the overall asymptomatic 
status and longevity of this patient as compared to the homozygous mutant patients with 
similar aortic isthmic Z-scores sets this patient clinically apart. There may be a role for 
factors other than just physical deformation of arteries and coarctation, in determining 
mortality and morbidity. 
While the phenotypic features overlapped with those of ATS, LDS and ARCL Type I, severe 
vascular abnormalities were the dominating feature in all. Aortic dilatation was more 
impressive than pulmonary artery dilatation, and more rapidly progressive, reflecting greater 
hemodynamic stresses within the aorta. Aortic isthmus was relatively narrow in all patients 
(median Z score −2) and in sharp contrast to the ascending aorta (median Z scores: +8.6) and 
descending aorta. Obstructive lesions were also noted in the branch pulmonary arteries, 
origins of arch branches and abdominal aorta. Reasons for this pattern of differential vascular 
growth is unclear and could point to differences in elastic fiber content at different sites. 
Ventricular hypertrophy seen in most patients was probably secondary to the obstructive 
lesions (coarctation, peripheral pulmonary stenosis). 
Interestingly, in the only case where a fetal molecular diagnosis was established through 
amniocentesis, no arterial deformation was observed on prenatal ultrasonogram (17 weeks) 
or, fetal autopsy (18 weeks). Family opted for termination of pregnancy in view of two 
previous infant deaths (both at 4 months of age), one of whom was a proven homozygous 
mutant. Although in the absence of a large study of controls in this specific population, it is 
difficult to prove that all homozygotes for the mutation would have lethal vasculopathy, the 
normal vascular phenotype in this fetus could indicate that early fetal diagnosis is dependent 
on mutation analysis. It could also be an indicator of progressive nature of the vasculopathy 
through fetal life, possibly in response to hemodynamic stresses and other molecular factors. 
It has previously been demonstrated in fetal calf model that while elastic fibers at term are 
large and predominantly made up of central amorphous elastin, those in very early fetal life 
consist of only microfibrils; progressive accumulation of elastin occurs with advancing 
gestation [35]. It is therefore likely that vascular deformation occurring due to abnormal 
elastic fiber formation would become manifest only in later pregnancy. 
Conclusions 
There exists a hitherto undescribed syndrome of arterial dilatation and tortuosity with lethal 
outcomes in the Malabar Mappila community, related to a novel mutation in the FBLN4 
gene. The actual disease burden in this community is likely to be much higher and needs 
extensive studies. Additionally, it has been once again shown that fibulin-4 is critical to 
human elastogenesis, vascular integrity, and survival. 
Methods 
Patient population 
This was a collaborative study conducted at Amrita Institute of Medical Sciences, Kochi, 
Kerala, India, and Center for Medical Genetics, Ghent, Belgium, between August 2004 and 
June 2011. Informed consent was obtained from families of all patients involved in the study. 
The study group comprised 22 patients identified to have dilatation and tortuosity of the aorta 
and its branches on echocardiography and/or radiological studies, during the study period. All 
patients underwent detailed clinical, phenotypic and socio-demographic characterization, 
specialized cardiovascular imaging, molecular genetic studies, histopathological studies 
(wherever feasible), and clinical follow-up for outcomes. Phenotypic features were described 
by a clinical geneticist. Of three neonates, where sickness and death precluded clinical 
examination by the geneticist, phenotype was recorded from clinical photographs in two; no 
phenotypic details were available for the third neonate (proband 16). Retinal examination was 
done for two patients (probands 3 and 4). 
Cardiovascular imaging 
Cardiovascular imaging was done using echocardiography and either 64-slice computed 
tomography (CT) (n = 20) or magnetic resonance imaging (MRI) (n = 2). Dimensions of the 
aorta and the pulmonary arteries were measured on CT or MRI at standard pre-defined 
locations. Z-scores were derived for selected measurements (aortic root at the sinuses of 
Valsalva, ascending aorta at the level of right pulmonary artery, isthmus just beyond the 
subclavian artery and main pulmonary artery) using published data sources [36-38]. Cerebral 
arteries were screened by CT scan in the eleven patients most recently clinically evaluated. 
Parental cardiovascular imaging was done by echocardiography in two, and cardiac MRI in 
seven cases. 
Molecular analyses 
Molecular genetic studies were carried out using DNA isolated from the peripheral blood 
leucocytes from all patients, and one or both parents of 19 patients. Studies included 
exclusion of mutations of SLC2A10 (associated with ATS) and TGFBR1 and TGFBR2 
(associated with LDS) in the first 3 patients (proband 1–3) recruited. Direct sequencing of 
FBLN4 was done for all patients. DNA from 100 individuals was used as control. 
Haplotyping around the FLBN4 gene was performed by PCR amplification of the following 
markers: D11S1205, D11S1883, D11S1889, D11S4155, D11S4113, D11S4095. Fragment 
analysis was done on ABI 3730XL. 
Histology 
A skin biopsy was obtained from one patient (proband 10) from the anterolateral aspect of the 
right thigh and studied after hematoxylin-eosin, and Orcein staining using standard 
histopathological techniques. 
Natural history 
Natural history was studied through clinical follow-up. CT scan was repeated for two 
(probands 4 and 5, 11 and 6 months after their respective initial CT evaluations) to determine 
rate of progression of arterial dilatation. Symptoms and circumstances surrounding deaths 
during follow-up were recorded. 
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Additional file 2. Echocardiogram (axial view). This video shows the dilated descending 
aorta compressing upon the heart posteriorly, in Proband 4. 
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